adefovir has been researched along with phenylephrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, X; Eichacker, PQ; Fitz, Y; Li, Y; Remy, K; Solomon, SB | 1 |
| Cui, X; Eichacker, PQ; Fitz, Y; Leppla, S; Li, Y; Moayeri, M; Suffredini, DA; Xu, W | 1 |
2 other study(ies) available for adefovir and phenylephrine
| Article | Year |
|---|---|
B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model.
Topics: Adenine; Animals; Antigens, Bacterial; Aorta; Bacterial Toxins; Cyclic AMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Organophosphonates; Phenylephrine; Rats; Rats, Sprague-Dawley; Second Messenger Systems; Up-Regulation; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2013 |
Shock and lethality with anthrax edema toxin in rats are associated with reduced arterial responsiveness to phenylephrine and are reversed with adefovir.
Topics: Adenine; Animals; Antigens, Bacterial; Aorta; Arterial Pressure; Arteries; Bacterial Toxins; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Organophosphonates; Phenylephrine; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Shock; Vasoconstrictor Agents | 2017 |